Skip to main content

Table 2 CMR chamber quantification

From: Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease

 

Controls

[n = 44]

MVP (all)

[n = 80]

MVP (no significant MR)

[n = 34]

“Borderline” MVP

[n = 13]

LVEDV (ml/m2)

73 [67–90]

98 [86–116]**

90 [85–101]**

83 [74–89]

LVESV (ml/m2)

30 [25–34]

39 [31–445**

37 [30–44]*

35 [32–37]

LVEF (%)

61 [57–65]

60 [57–66]

60 [57–64]

59 [56–62]

LV mass (g/ m2)

51 [42–59]

54 [46–65]

48 [43–59]

47 [41–54]

LV end-diastolic diameter (cm/ m2)

2.6 [2.3–2.8]

2.8 [2.5–3.2]**

2.7 [2.5–3.2]*

2.8 [2.5–2.9]*

LV end-systolic diameter (cm/ m2)

1.7 [1.5–2.0]

1.9 [1.7–2.2]*

1.9 [1.8–2.1]*

1.9 [1.8–2.1]

Basal inferolateral thickness in diastole (cm)

0.7 [0.6–0.9]

0.8 [0.7–1.0]*

0.7 [0.6–0.9]

0.7 [0.6–0.7]

Basal inferolateral thickness in systole (cm)

1.2 [1.1–1.4]

1.5 [1.3–1.7]**

1.5 [1.3–1.6]**

1.3 [1.2–1.4]

Mid inferolateral thickness in diastole (cm)

0.6 [0.5–0.8]

0.6 [0.5–0.7]

0.6 [0.4–0.7]*

0.4 [0.3–0.5]**

Mid inferolateral thickness in systole (cm)

1 [0.9–1.2]

1 [0.8–1.2]

1 [0.7–1.2]

0.7 [0.6–0.8]**

Basal-to-mid inferolateral end-diastolic thickness ratio

1.1 [1–1.3]

1.4 [1.1–1.7]**

1.4 [1–1.6]*

1.7 [1.3–1.7]**

Basal-to-mid inferolateral end-systolic thickness ratio

1.2 [1–1.4]

1.5 [1.2–1.7]**

1.6 [1.3–1.8]**

1.9 [1.8–2.0]**

RVEDV (ml/ m2)

76 [69–86]

85 [75–104]*

85 [81–101]*

74 [63–99]

RVESV (ml/m2)

33 [28–38]

36 [28–47]

37 [28–48]

37 [27–42]

RVEF (%)

57 [55–62]

59 [53–65]

59 [53–63]

56 [51–60]

LA volume (ml/ m2)

38 [30–43]

50 [40–67]**

41 [34–49]

50 [36–59]*

Mitral valve regurgitant fraction (%)

4 [0–6]

20 [11–32]*

9 [1–13]

N/A

LGE performed

44 (100%)

70 (85%)

25 (74%)

11 (85%)

Myocardial LGE

2 (5%)

23 (33%)**

8 (32%)*

3 (27%)

Intramyocardial pattern

2 (5%)

16 (23%)*

4 (16%)*

3 (27%)

Inferolateral LGE

0 (0%)

22 (32%)*

8 (33%)*

2 (18%)

  1. Values expressed as n (%) or medians [interquartile range]
  2. LA left atrium. LGE late gadolinium enhancement. LV left ventricle. LVEDV left ventricle end-diastolic volume. LVEF left ventricle ejection fraction. LVESV left ventricle. N/A not applicable. RVEDV right ventricular end-diastolic volume. RVEF right ventricular ejection fraction. RVESV: right ventricular end-systolic volume. SAX short axis view
  3. *P Value < 0.05 versus controls. **P Value < 0.01 versus controls